Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US9580407B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9580407-B2 |
| Application number | US-201314649299-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 3, 2013 |
| Priority date | Dec 7, 2012 |
| Publication date | Feb 28, 2017 |
| Grant date | Feb 28, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A novel process is provided for the efficient preparation of an asymmetric compound of structural formula I: comprising a copper-catalyzed, carbon-nitrogen cross-coupling step. The process described as part of the present invention can be used to manufacture poly (ADP-ribose) polymerase (PARP) inhibitors, which may be useful for the treatment of cancer. In particular, the present invention describes a process for the manufacture of the PARP inhibitor, 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide.
Opening claim text (preview).
What is claimed is: 1. A process for preparing a compound of formula I: wherein R 2 is hydrogen or an amine protecting group, comprising: (a) carbon-nitrogen cross-coupling of (i) an indazole of formula II containing a protected amide: wherein R 1 is C 1-8 alkyl, C 3-8 cycloalkyl, C 4-8 heterocyclyl, aryl, heteroaryl or arylC 1-8 alkyl, optionally substituted with one to three aryl, heteroaryl, C 3-8 cycloalkyl or OC 1-8 alkyl; and (ii) a piperidine compound of formula III: wherein R 3 is a leaving group and R 2 is as provided above; in the presence of a catalytic amount of a copper salt, a suitable ligand, a base, and a solvent, forming a compound of formula IV: wherein R 1 and R 2 are as provided above; and, (b) de-protecting the amide of the compound of formula IV. 2. The process of claim 1 , wherein the copper salt is a Cu(I) or Cu(II) salt selected from CuI, CuCl, CuCl 2 , CuBr, CuBr.S(CH 3 ) 2 , CuBr 2 , CuF 2 , CuOAc, Cu(OAc) 2 , Cu 2 O, CuO, CuSO 4 , Cu(OTf) 2 , Cu(OMs) 2 , Cu(OTs) 2 , Cu(NO 3 ) 2 , or Cu(BF 4 ) 2 CuBr. 3. The process of claim 2 , wherein the copper salt is CuBr. 4. The process of claim 1 , wherein the copper salt is present in an amount less than or equal to about 10 mol % relative to the piperidine compound of formula III. 5. The process of claim 4 , wherein the copper salt is present in an amount less than or equal to about 5 mol % relative to the piperidine compound of formula III. 6. The process of claim 3 , wherein CuBr is present in an amount of about 5 mol % relative to the piperidine compound of formula III. 7. The process of claim 1 , wherein R 2 is an amine protecting group, and wherein the process further comprises de-protecting the piperidyl nitrogen of the compound of formula IV, forming the compound of formula V: 8. The process of claim 7 , wherein R 2 is an amine protecting group selected from formyl, acetyl, trifluoroacetyl, benzyl, benzoyl, carbamate, benzyloxycarbonyl, p-methoxybenzyl carbonyl, tert-butoxycarbonyl, trimethylsilyl, 2-trimethylsilyl-ethanesulfonyl, trityl and substituted trityl groups, allyloxycarbonyl, 9-fluorenylmethyloxycarbonyl, nitro-veratryloxycarbonyl, p-methoxybenzyl or tosyl. 9. The process of claim 8 , wherein R 2 is tert-butoxycarbonyl. 10. The process of claim 1 , wherein R 1 is C 1-8 alkyl, optionally substituted with one to three phenyl. 11. The process of claim 10 , wherein R 1 is tert-butyl, cumyl or trityl. 12. The process of claim 11 , wherein R 1 is tert-butyl. 13. The process of claim 1 , wherein R 3 is Br. 14. The process of claim 1 , wherein the ligand is selected from dimethylglycine, 8-hydroxyquinoline, phenanthroline, neocuproine, 3,4,7,8-tetramethyl-1,10-phenanthroline, 2,2,6,6-tetramethyl-3,5-heptanedione, 2,6-dimethyl-3,5-heptanedione, 2-isobutyrylcyclohexanone, 2-acetylcyclohexanone, 2,4-pentanedione or 3,5-heptanedione. 15. The process of claim 14 , wherein the ligand is dimethylglycine or 8-hydroxyquinoline. 16. The process of claim 15 , wherein the ligand is 8-hydroxyquinoline. 17. The process of claim 1 , wherein the base is selected from K 2 CO 3 , K 3 PO 4 , K2HPO4, Cs 2 CO 3 , KHCO 3 , Na 2 CO 3 or NaHCO 3 . 18. The process of claim 17 , wherein the base is K 2 CO 3 . 19. The process of claim 1 , wherein the solvent is selected from dimethyl sulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMAc), 1,3-dimethyl-2-imidazolidinone (DMI), N-methyl-2-pyrrolidone (NMP), sulfolane, pyridine, 2-picoline, 3-picoline, 4-picoline, toluene, o-xylene, m-xylene, p-xylene, dioxane, chlorobenzene or anisole, and combinations thereof. 20. The process of claim 19 , wherein the solvent is dimethylacetamide (DMAc). 21. The process of claim 1 , wherein the carbon-nitrogen cross-coupling of step (a) is performed at a temperature of between about 90° C. and about 130° C. 22. The process of claim 1 , wherein carbon-nitrogen cross-coupling of step (a) is performed in the presence of CuBr in the amount of about 5 mol % relative to the piperidine compound of formula IV, the ligand 8-hydroxyquinoline, the base K 2 CO 3 , and the solvent dimethylacetamide (DMAc), at a temperature of about 110° C. 23. The process of claim 22 , wherein R 1 is tert-butyl, R 2 is tert-butoxycarbonyl, and R 3 is Br, and wherein the process further comprises de-protecting the piperidyl nitrogen of the compound of formula IV, forming the compound of formula V: 24. A process for preparing a compound of formula VI: comprising: (a) carbon-nitrogen cross-coupling of (i) the indazole of formula VII and (ii) the piperidine compound of formula VIII, wherein Boc is tert-butoxycarbonyl: in the presence of a catalytic amount of a copper salt, a suitable ligand, a base, and a solvent, forming the compound of formula IX: and, (b) de-protecting both the amide and the piperidyl nitrogen of the compound of formula IX in the presence of p-TsOH (aq), forming the compound of formula VI. 25. The process of claim 24 , wherein the carbon-nitrogen cross-coupling of step (a) is performed in the presence of CuBr in the amount of about 5 mol % relative to the piperidine compound of formula VIII, the ligand 8-hydroxyquinoline, the base K 2 CO 3 , and the solvent dimethylacetamide (DMAc), at a temperature of about 110° C.
linked by a carbon chain containing aromatic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.